CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-26 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-01-26 | Bancel Stephane Chief Executive Officer | Sale | −4,295 | $188.09 | $808K | 5,447,651 |
| 2023-01-26 | Bancel Stephane Chief Executive Officer | Sale | −3,835 | $189.21 | $726K | 5,443,816 |
| 2023-01-26 | Bancel Stephane Chief Executive Officer | Sale | −8,823 | $190.27 | $1.7M | 5,434,993 |
| 2023-01-26 | Bancel Stephane Chief Executive Officer | Sale | −15,847 | $191.08 | $3.0M | 5,419,146 |
| 2023-01-26 | Bancel Stephane Chief Executive Officer | Sale | −3,289 | $192.16 | $632K | 5,415,857 |
| 2023-01-26 | Bancel Stephane Chief Executive Officer | Sale | −3,911 | $192.92 | $755K | 5,411,946 |
| 2023-01-26 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,707,155 | ||
| 2023-01-25 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-01-25 | Bancel Stephane Chief Executive Officer | Sale | −6,790 | $190.65 | $1.3M | 5,445,156 |
| 2023-01-25 | Bancel Stephane Chief Executive Officer | Sale | −6,260 | $191.51 | $1.2M | 5,438,896 |
| 2023-01-25 | Bancel Stephane Chief Executive Officer | Sale | −19,850 | $192.32 | $3.8M | 5,419,046 |
| 2023-01-25 | Bancel Stephane Chief Executive Officer | Sale | −7,100 | $193.39 | $1.4M | 5,411,946 |
| 2023-01-25 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,747,155 | ||
| 2023-01-25 | AFEYAN NOUBAR Director | Sale | −10,000 | $194.33 | $1.9M | 2,237,209 |
| 2023-01-19 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-01-19 | Bancel Stephane Chief Executive Officer | Sale | −9,341 | $191.16 | $1.8M | 5,442,605 |
| 2023-01-19 | Bancel Stephane Chief Executive Officer | Sale | −18,438 | $191.88 | $3.5M | 5,424,167 |
| 2023-01-19 | Bancel Stephane Chief Executive Officer | Sale | −9,517 | $192.84 | $1.8M | 5,414,650 |
| 2023-01-19 | Bancel Stephane Chief Executive Officer | Sale | −2,704 | $193.61 | $524K | 5,411,946 |
Page 59 of 66 · 1,314 trades